90732
Medical code 90732 refers to the administration of the pneumococcal vaccine, specifically the 23-valent pneumococcal polysaccharide vaccine (PPSV23). This vaccine is typically given to protect against pneumonia and other infections caused by pneumococcal bacteria. It's commonly administered to certain high-risk populations, including older adults and individuals with specific health conditions. The code is used for billing and insurance purposes to indicate the specific vaccine administered.
no
Influenza vaccine, intramuscular
Pneumococcal pneumonia, caused by the bacterium Streptococcus pneumoniae, has vaccines available to help prevent infection. There are two main types of pneumococcal vaccines: the pneumococcal conjugate vaccine (PCV13 or PCV15) and the pneumococcal polysaccharide vaccine (PPSV23). These vaccines are recommended for certain populations, including young children, older adults, and individuals with specific health conditions. Vaccination can significantly reduce the risk of severe illness and complications associated with pneumococcal pneumonia.
Immunization administration; each additional vaccine
CPT code 90713 refers to the administration of the pneumococcal polysaccharide vaccine (PPSV23). The National Drug Code (NDC) number associated with this vaccine can vary based on the manufacturer. To find the specific NDC number for a particular product, it is best to consult the vaccine packaging or check the FDA's NDC Directory.
Pneumococcal polysaccharide disease is caused by a bacteria. It can be deadly but a vaccine was developed to head off the disease before it starts. The vaccine works when a small amount of the bacteria is injected into the patient and his or her immunity works against the disease, causing immunity.
CPT code 90714 refers to the administration of the pneumococcal conjugate vaccine (PCV13) for individuals aged 6 weeks through 17 years. This vaccine protects against infections caused by Streptococcus pneumoniae, which can lead to serious conditions such as pneumonia, meningitis, and bloodstream infections. It is commonly used in pediatric immunization schedules to enhance community immunity against pneumococcal diseases.
CPT Code 90687 refers to the pneumococcal conjugate vaccine (PCV13) for adults. There is no specific age limit associated with this code; however, it is primarily recommended for adults aged 19 years and older, particularly those at increased risk for pneumococcal disease. Always refer to current guidelines for any updates or specific recommendations.
The procedure code 90718, which was previously used for the administration of the Human Papillomavirus (HPV) vaccine, has been replaced by code 90651. Code 90651 specifically refers to the HPV vaccine for individuals aged 9 through 45 years. It is important to stay updated with coding resources or the American Medical Association (AMA) for any changes in vaccine codes.
The CPT procedure code for vaccine administration for an 18-month-old is typically 90460 for the first vaccine and 90461 for each additional vaccine administered on the same day. These codes are used for documenting the administration of vaccines to patients aged 18 months or younger. Always check the latest coding guidelines or updates, as codes may change.
Yes, Medicaid in North Carolina covers the pneumonia vaccine for eligible beneficiaries. This includes both the pneumococcal conjugate vaccine (PCV13) and the pneumococcal polysaccharide vaccine (PPSV23). Coverage typically applies to individuals who meet certain age criteria or have specific health conditions. It's best to check with a healthcare provider or Medicaid for the most current information regarding coverage and eligibility.